The global cell culture market is anticipated to grow with a CAGR of 11.8% through the year 2026

This report studies the global market size of Cell Culture, and especially focuses on the key regions like the United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Cell Culture production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

Supplying top quality fetal bovine serum, Biosera-US.com is presenting the $25 two-day flat rate for shipping on all any FBS order.

STEMCELL Technologies Inc. to Launch TeSR-E8 - a Novel Medium for Human Embryonic and Induced Pluripotent Stem Cells - and New STEMdiff Kits for Differentiation of these cell types

CYTOO Inc,the US subsidiary of CYTOO SA, is pleased to announce a partnership with PharmaNest, a contract operations organization who commercializes breakthrough International IND-Enabling Technologies and Services for the US Markets.

Greiner Bio- One North America, Inc. would like to offer a unique and extensive CELLMASTERTM Roller Bottle product portfolio, designed to fulfill different requirements for the production of virus vaccines or recombinant proteins used for therapeutic

Greiner Bio-One North America, Inc. is pleased to announce the grand opening of its newly expanded warehouse facility located in Monroe, North Carolina as of January 31st, 2010.This expansion will allow us to continue to offer quality products.

InQ Biosciences will introduce its InQ™ Cell Research System - the first fully integrated cell growth and cell analysis system that combines a dynamically controlled sample environment with powerful imaging and real-time data collection.

International Stem Cell Corporation announced that its oocyte collection and activation protocol has received the approval of an Institutional Review Board, a Federal requirement for all studies enrolling human subjects, and ensures appropriate subj

International Stem Cell Corporation announced that the United States Patent and Trademark Office has granted ISCO a patent relating to the company's development of human non-embryonic parthenogenetic stem cells. Human parthenogenetic stem cells are

International Stem Cell Corporation, an international pioneer and leader in stem cell research, announced that its wholly owned subsidiary, Lifeline Skin Care Inc., has achieved positive results in human safety tests of its cosmetic products and is m